Epstein Barr Virus (EBV) Early Protein

Produktnummer ABIN7489960

Dieses Native Epstein Barr Virus (EBV) Early-Protein wird in Escherichia coli (E. coli) produziert.

Kurzübersicht für Epstein Barr Virus (EBV) Early Protein (ABIN7489960)

Target: Epstein Barr Virus (EBV) Early

Protein-Typ: Native

Spezies: Epstein-Barr Virus (EBV)

Quelle: Escherichia coli (E. coli)

Applikation: Immunoassay (IA)

Produktdetails

Spezifität: Epstein Barr Virus (EBV) Early Antigen

Produktmerkmale: E. coli derived recombinant protein

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

The protein contains a fragment of EBV (Epstein-Barr virus) early antigen p54. They are produced in E. coli and purified by affinity chromatography in the presence of urea. Purity of ≥ 95 % is confirmed via SDS-PAGE (Coomassie staining). The antigens are suitable for the detection of IgG and IgM antibodies against EBV. The main antigen for the detection of IgM antibodies is the capsid antigen p18.. Molecular mass: 45 kDa.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: phosphate buffered saline at pH 7.4, containing 4 M urea

Lagerung: -80 °C

Antigendetails

Target: Epstein Barr Virus (EBV) Early

Hintergrund: The Epstein-Barr Virus, also called Human Herpesvirus 4 (HHV-4), is one of eight known human herpesvirus types and is one of the most common viruses in humans. It is best known for causing mononucleosis or glandular fever and is also associated with certain forms of cancer.

Molekulargewicht: 45 kDa